Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00107289
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2005-04-05
Brief Title:
Iodine I 131 Metaiodobenzylguanidine in Treating Patients with Recurrent Progressive or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Memorial Sloan Kettering Cancer Center